301
Participants
Start Date
May 26, 2020
Primary Completion Date
April 28, 2021
Study Completion Date
May 7, 2021
BCG vaccine
Patients susceptible to SARS-CoV-2 infection will be vaccinated with one intradermal injection of 0.1ml of BCG vaccine
Placebo
Patients susceptible to SARS-CoV-2 infection will be vaccinated with one intradermal injection of 0.1ml of sodium chloride 0.9%
1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens
2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens
3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens
"4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School", Athens
General Hospital of Korinthos, Corinth
General Hospital of Argolida - Nafplion Unit, Nafplion
Department of Internal Medicine, General Hospital of Karditsa, Karditsa
1st Department of Internal Medicine, General University Hospital of Ioannina, Ioannina
Department of Pulmonary Medicine- General Hospital of Kerkyra, Corfu
General Hospital of Ptolemaida MPODOSAKEIO, Ptolemaida
1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloniki
General Hospital of Imathia - Veria Unit, Véria
2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupoli
Department of Therapeutics, Alexandra General Hospital, Athens
Department of Internal Medicine, Patras University Hospital, Pátrai
Hellenic Institute for the Study of Sepsis
OTHER